Get the Stockscreener App
0.144
4.70%
-0.0071
After Hours:
.1413
-0.0027
-1.87%
Biolase Inc stock is currently priced at $0.144, with a 24-hour trading volume of 532.23K.
It has seen a -4.70% decreased in the last 24 hours and a -19.69% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.1502 pivot point. If it approaches the $0.1396 support level, significant changes may occur.
Previous Close:
$0.1511
Open:
$0.152
24h Volume:
532.23K
Market Cap:
$4.79M
Revenue:
$49.16M
Net Income/Loss:
$-20.63M
P/E Ratio:
-0.000544
EPS:
-264.93
Net Cash Flow:
$-15.40M
1W Performance:
-1.97%
1M Performance:
-19.69%
6M Performance:
-91.00%
1Y Performance:
-33.02%
1D Range:
$0.1409
$0.152
52W Range:
$0.0638
$9.35
Biolase Inc Stock (BIOL) Company Profile
Name
Biolase Inc
Sector
Industry
Phone
949 361 1200
Address
27042 Towne Centre Drive, Suite 270, Foothill Ranch, CA
Biolase Inc Stock (BIOL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-19-19 | Initiated | The Benchmark Company | Speculative Buy |
| Apr-25-17 | Initiated | Singular Research | Buy |
| May-13-14 | Downgrade | WallachBeth | Buy → Hold |
| Nov-12-13 | Reiterated | WallachBeth | Buy |
| Aug-08-13 | Reiterated | WallachBeth | Buy |
| Jun-17-13 | Initiated | WallachBeth | Buy |
| Mar-18-13 | Reiterated | Northland Capital | Outperform |
| Mar-07-13 | Reiterated | Northland Capital | Outperform |
| Sep-07-12 | Initiated | Northland Securities | Outperform |
View All
Biolase Inc Stock (BIOL) Latest News
Future Penny Stocks Investing Trends, 3 To Consider
PennyStocks
Top Pros for Investing in Penny Stocks
PennyStocks
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Dow Dips 200 Points; Nike Shares Fall After Q3 Results
Benzinga
US Stocks Edge Lower; FedEx Posts Upbeat Earnings
Benzinga
Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Benzinga
Biolase Inc Stock (BIOL) Financials Data
Biolase Inc (BIOL) Revenue 2024
BIOL reported a revenue (TTM) of $49.16 million for the quarter ending December 31, 2023, a +1.45% rise year-over-year.
Biolase Inc (BIOL) Net Income 2024
BIOL net income (TTM) was -$20.63 million for the quarter ending December 31, 2023, a +27.95% increase year-over-year.
Biolase Inc (BIOL) Cash Flow 2024
BIOL recorded a free cash flow (TTM) of -$15.40 million for the quarter ending December 31, 2023, a +49.48% increase year-over-year.
Biolase Inc (BIOL) Earnings per Share 2024
BIOL earnings per share (TTM) was -$37.35 for the quarter ending December 31, 2023, a +90.92% growth year-over-year.
About Biolase Inc
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.
0.19%
0.61%
Cap:
|
Volume (24h):